Inozyme Pharma, Inc. (INZY) Ownership

$4.00

north_east
$0.01 (0.25%)
Day's range
$4
Day's range
$4

Inozyme Pharma, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BERYL CAPITAL MANAGEMENT LLC 08/14/2025 6.32 M $25.29 M   100.00% 9.83%
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC 08/13/2025 4.49 M $17.98 M   0.00% 6.99%
GLAZER CAPITAL, LLC 08/14/2025 4.33 M $17.32 M   100.00% 6.74%
SOFINNOVA INVESTMENTS, INC. 08/14/2025 4.28 M $17.12 M   0.00% 6.66%
ODDO BHF ASSET MANAGEMENT SAS 08/14/2025 3.20 M $12.80 M   100.00% 4.98%
TRIUM CAPITAL LLP 08/11/2025 3.17 M $12.69 M   100.00% 4.94%
BLACKROCK, INC. 08/12/2025 2.66 M $10.65 M   -28.88% 4.14%
VANGUARD GROUP INC 08/11/2025 2.50 M $9.99 M   -9.42% 3.89%
NEA MANAGEMENT COMPANY, LLC 08/14/2025 2.44 M $9.75 M   0.00% 3.79%
ALPINE ASSOCIATES MANAGEMENT INC. 08/05/2025 2.19 M $8.75 M   100.00% 3.40%
AFFINITY ASSET ADVISORS, LLC 08/13/2025 1.75 M $7.00 M   -54.77% 2.72%
GABELLI FUNDS LLC 08/13/2025 1.46 M $5.83 M   100.00% 2.27%
GARDNER LEWIS ASSET MANAGEMENT L P 08/12/2025 1.26 M $5.03 M   100.00% 1.96%
GEODE CAPITAL MANAGEMENT, LLC 08/08/2025 1.22 M $4.89 M   -0.78% 1.90%
OMERS ADMINISTRATION CORP 08/13/2025 1.12 M $4.47 M   100.00% 1.74%
MAN GROUP PLC 08/14/2025 670.16 K $2.68 M   100.00% 1.04%
KNOTT DAVID M JR 08/11/2025 666.20 K $2.66 M   0.00% 1.04%
GABELLI & CO INVESTMENT ADVISERS, INC. 08/13/2025 617.00 K $2.47 M   100.00% 0.96%
WOODLINE PARTNERS LP 08/14/2025 535.19 K $2.14 M   -46.68% 0.83%
MILLENNIUM MANAGEMENT LLC 08/14/2025 481.80 K $1.93 M   -61.29% 0.75%
RENAISSANCE TECHNOLOGIES LLC 08/13/2025 470.50 K $1.88 M   -16.65% 0.73%
SANOFI 07/29/2025 443.26 K $1.77 M   0.00% 0.69%
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 08/13/2025 377.23 K $1.51 M   100.00% 0.59%
OXFORD ASSET MANAGEMENT LLP 08/14/2025 361.56 K $1.45 M   100.00% 0.56%
STATE STREET CORP 08/14/2025 331.77 K $1.33 M   -66.73% 0.52%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 08/14/2025 260.71 K $1.04 M   100.00% 0.41%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 224.98 K $899.92 K   110.51% 0.35%
GROUPE LA FRANCAISE 08/13/2025 223.80 K $895.20 K   100.00% 0.35%
WATER ISLAND CAPITAL LLC 08/14/2025 201.78 K $807.10 K   100.00% 0.31%
GOLDMAN SACHS GROUP INC 08/14/2025 155.01 K $620.03 K   -33.63% 0.24%
CREDIT INDUSTRIEL ET COMMERCIAL 08/07/2025 149.20 K $596.80 K   100.00% 0.23%
NORTHERN TRUST CORP 08/13/2025 139.07 K $556.30 K   -67.52% 0.22%
CITADEL ADVISORS LLC 08/14/2025 128.70 K $514.80 K   832.61% 0.20%
MORGAN STANLEY 08/15/2025 124.74 K $498.94 K   -8.60% 0.19%
DIMENSIONAL FUND ADVISORS LP 08/12/2025 120.15 K $480.58 K   -52.34% 0.19%
PENDERFUND CAPITAL MANAGEMENT LTD. 08/14/2025 90.70 K $362.80 K   100.00% 0.14%
PRELUDE CAPITAL MANAGEMENT, LLC 08/14/2025 84.65 K $338.59 K   100.00% 0.13%
TWO SIGMA INVESTMENTS, LP 08/14/2025 82.61 K $330.44 K   -6.22% 0.13%
AQR CAPITAL MANAGEMENT LLC 08/14/2025 80.61 K $322.46 K   1.94% 0.13%
SUMMITTX CAPITAL, L.P. 08/14/2025 79.57 K $318.30 K   100.00% 0.12%
JAIN GLOBAL LLC 08/14/2025 70.64 K $282.57 K   100.00% 0.11%
XTX TOPCO LTD 08/12/2025 70.17 K $280.68 K   -36.60% 0.11%
GAMCO INVESTORS, INC. ET AL 08/13/2025 60.00 K $240.00 K   100.00% 0.09%
WOLVERINE ASSET MANAGEMENT LLC 08/04/2025 58.44 K $233.78 K   100.00% 0.09%
JPMORGAN CHASE & CO 08/12/2025 57.43 K $229.74 K   84.25% 0.09%
JANE STREET GROUP, LLC 08/14/2025 55.77 K $223.06 K   100.00% 0.09%
EXODUSPOINT CAPITAL MANAGEMENT, LP 08/13/2025 55.52 K $222.00 K   100.00% 0.09%
BANK OF AMERICA CORP /DE/ 08/14/2025 52.45 K $209.82 K   -27.50% 0.08%
MARSHALL WACE, LLP 08/13/2025 50.90 K $203.60 K   100.00% 0.08%
HARVEST MANAGEMENT LLC 08/14/2025 50.00 K $200.00 K   100.00% 0.08%

Inozyme Pharma, Inc. institutional Ownership - FAQ's

During the previous two years, 93 institutional investors and hedge funds held shares of Inozyme Pharma, Inc.. The most heavily invested institutionals were:

UBS Group AG: 0

ODDO BHF ASSET MANAGEMENT SAS: 0

INTECH INVESTMENT MANAGEMENT LLC: 0

XTX Topco Ltd: 0

OMERS ADMINISTRATION Corp: 0

Woodline Partners LP: 0

78.66% of Inozyme Pharma, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 5.11 M shares in the last 24 months. This purchase volume represents approximately $20.43 M in transactions.